• Info
  • Insider Ownership

Insider Trading & Ownership of FRANKLYN G. PRENDERGAST

Summary
The estimated net worth of FRANKLYN G. PRENDERGAST is at least $359,564 dollars as of 04 Oct 2023. FRANKLYN G. PRENDERGAST is the Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $359,564.
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when FRANKLYN G. PRENDERGAST files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of FRANKLYN G. PRENDERGAST

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IMNM Immunome Inc. Director $359,564 02 Oct 2023
LTRN Lantern Pharma Inc. Director 04 Nov 2021
NBSE NeuBase Therapeutics, Inc. Director 09 Sep 2022

Insider Transactions Reported by FRANKLYN G. PRENDERGAST:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.